Fat emulsion for intravenous administration: clinical experience with intralipid 10%.
A 10% soybean oil emulsion (Intralipid 10%), used extensively in Europe for intravenous alimentation, has now been clinically evaluated in the United States. Controlled studies have shown that the soybean oil emulsion can be substituted for glucose to supply one-third to two-thirds of the total calories, and can be administered peripherally without significant vein irritation. Essential fatty acid deficiencies, frequently encountered in patients dependent on parenteral alimentation with fat-free solutions, are prevented and corrected by use of this preparation. Data on long-term tolerance to Intralipid 10% infusions are presented for 292 patients treated for more than 6,000 patient days. The soybean oil emulsion was usually well tolerated. Side effects were reported in two of 133 adults and 12 of 159 pediatric patients.
D000328:Adult; D002648:Child; D003677:Deficiency Diseases / Q000209:etiology; D004041:Dietary Fats / Q000008:administration & dosage* / Q000009:adverse effects / Q000592:standards; D004655:Emulsions; D005069:Evaluation Studies as Topic; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D007223:Infant; D010288:Parenteral Nutrition / Q000009:adverse effects / Q000592:standards; D013025:Glycine max
D004041:Dietary Fats; D004655:Emulsions; D005227:Fatty Acids